Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001722024-17-000002
Filing Date
2017-11-15
Accepted
2017-11-15 21:07:31
Documents
1
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_151079803497141.html 3  
1 FORM 3 wf-form3_151079803497141.xml 3 3002
  Complete submission text file 0001722024-17-000002.txt   4610
Mailing Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451
Business Address 890 WINTER STREET, SUITE 230 WALTHAM MA 02451 781-819-5704
Arsanis, Inc. (Issuer) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101
Business Address 385 EAST COLORADO BOULEVARD SUITE 299 PASADENA CA 91101 626-578-0777
Alexandria Venture Investments, LLC (Reporting) CIK: 0001722024 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38295 | Film No.: 171206526